Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Interest Coverage Ratio of 2.88 for Q1 2026, up 75.77% year-over-year from 1.64 in Q1 2025, and up 41.53% quarter-over-quarter from 4.92 in Q4 2025.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 2.88 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 75.77% year-over-year to 2.88; the TTM figure through Mar 2026 stood at 6.17 (up 48.65% YoY), while the FY2025 annual figure was 0.23, up 65.99% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.88, up from 4.92 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.21 in Q2 2025, with the low at 61.78 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 15.79 (2024), against an average of 23.98.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio tumbled 319.36% in 2023, then surged 98.67% in 2025.
- Tarsus Pharmaceuticals' Interest Coverage Ratio stood at 21.76 in 2022, then plunged by 141.41% to 52.54 in 2023, then jumped by 79.9% to 10.56 in 2024, then surged by 53.42% to 4.92 in 2025, then surged by 41.53% to 2.88 in 2026.
- Business Quant data shows TARS's Interest Coverage Ratio at 2.88 in Q1 2026, 4.92 in Q4 2025, and 6.41 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Tarsus Pharmaceuticals | 3.96 Bn | 3.51 Bn | 161.80 Mn | -9.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.23 |
| Mar 31, 2026 | -2.88 |
| Dec 31, 2025 | -3.60 |
| Sep 30, 2025 | -6.41 |
| Jun 30, 2025 | -9.90 |
| Mar 31, 2025 | -11.88 |
| Dec 31, 2024 | -10.56 |
| Sep 30, 2024 | -10.29 |
| Jun 30, 2024 | -15.79 |
| Mar 31, 2024 | -38.34 |
| Dec 31, 2023 | -44.94 |
| Sep 30, 2023 | -47.71 |
| Jun 30, 2023 | -40.27 |
| Mar 31, 2023 | -36.48 |
| Dec 31, 2022 | -21.76 |
| Sep 30, 2022 | -36.19 |
| Jun 30, 2022 | -9.60 |
| Mar 31, 2022 | -61.78 |